文献速递创伤与烧伤复苏、休克与脓毒症

呼气末二氧化碳作为创伤患者死亡预测指标:系统评价与荟萃分析

End-tidal carbon dioxide as a predictor of mortality in trauma patients: A systematic review and meta-analysis.
PubMed 文献 · J Trauma Acute Care Surg · 2026-03-24
一句话结论创伤患者低呼气末二氧化碳与死亡率升高相关(合并OR 9.59,95%CI 3.35-27.49),作者认为院前和急诊科可考虑测量呼气末二氧化碳用于风险分层。

该系统评价与荟萃分析纳入8项观察性研究(n=2407),均为美国研究,其中3项为急诊科前瞻性队列、5项为院前回顾性队列,按原作者定义的呼气末二氧化碳低值(≤30至≤33 mmHg不等)与正常/高值分层。低呼气末二氧化碳组死亡率为21.8%,正常/高值组为12.0%,合并OR 9.59(95%CI 3.35-27.49;P<0.001),敏感性分析剔除任一研究后OR范围5.88-15.23。4项报告输血的研究显示低呼气末二氧化碳组输血率7.4% vs 1.3%,合并OR 3.32(95%CI 2.12-6.15;P<0.001)。作者认为呼气末二氧化碳低成本、无创,院前和急诊科可考虑测量并用于风险分层,但低值阈值尚需标准化并需前瞻性研究。

要点

  • 创伤患者低呼气末二氧化碳(原文各研究定义为≤30至≤33 mmHg)与全因死亡率升高相关:死亡率21.8% vs 12.0%,合并OR 9.59(95%CI 3.35-27.49;P<0.001)。
  • 低呼气末二氧化碳与输血几率升高相关:4项研究报告输血率7.4% vs 1.3%,合并OR 3.32(95%CI 2.12-6.15;P<0.001)。
  • 剔除任一研究的敏感性分析结果稳健,OR范围5.88-15.23;急诊科前瞻性研究异质性(I²≈28%)低于回顾性研究(I²≈83%)。
  • 荟萃回归显示初始收缩压越高与死亡 odds 越低相关(相关系数-0.101;95%CI -0.17至-0.029;P=0.0054)。
  • 作者认为鉴于呼气末二氧化碳低成本、无创,院前和急诊科可考虑测量并用于风险分层,但低、正常、高值的标准化阈值及前瞻性研究尚待确立。

适用人群与场景

  • 纳入报告呼气末二氧化碳并按低值与正常/高值分层结局的创伤患者,共8项观察性研究(n=2407),其中3项为急诊科前瞻性队列、5项为院前回顾性队列,全部基于美国。

诊断标准与关键阈值

  • 低呼气末二氧化碳阈值由各原始研究作者定义,范围为≤30至≤33 mmHg。

研究设计与关键结果

  • 研究类型为系统评价与荟萃分析,纳入8项观察性研究(n=2407):3项急诊科前瞻性队列、5项院前回顾性队列,均为美国研究。
  • 总体732例(30%)患者为低呼气末二氧化碳;低呼气末二氧化碳组死亡率21.8% vs 正常/高值组12.0%,合并OR 9.59(95%CI 3.35-27.49;P<0.001)。
  • 剔除任一研究的敏感性分析结果稳健,OR范围5.88-15.23。
  • 急诊科前瞻性研究异质性较低(I²≈28%),回顾性研究异质性较高(I²≈83%)。
  • 4项报告输血的研究中,低呼气末二氧化碳组输血率7.4% vs 1.3%,合并OR 3.32(95%CI 2.12-6.15;P<0.001)。
  • 荟萃回归显示初始收缩压越高与死亡 odds 越低相关(相关系数-0.101;95%CI -0.17至-0.029;P=0.0054)。

证据类型、等级与局限

  • 证据类型为系统评价/荟萃分析,原文标注证据等级为Level III。
  • 全部纳入研究均为观察性研究(3项前瞻性急诊科队列、5项回顾性院前队列),低呼气末二氧化碳阈值在各研究间不一致(≤30至≤33 mmHg)。
  • 回顾性研究异质性较高(I²≈83%),急诊科前瞻性研究异质性较低(I²≈28%)。
  • 作者指出需要标准化低、正常、高呼气末二氧化碳阈值并开展前瞻性研究以优化临床实施。

对床旁实践的改变

  • 作者认为鉴于呼气末二氧化碳低成本、无创,院前和急诊科可考虑测量呼气末二氧化碳并用于创伤患者风险分层。
  • 作者指出低、正常、高呼气末二氧化碳的标准化阈值及前瞻性研究尚待确立,以优化临床实施。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: End-tidal carbon dioxide (ETCO₂) is a noninvasive marker reflecting the interplay of ventilation, perfusion, and metabolism. Its prognostic value as a predictor for mortality in trauma patients remains variably defined across prehospital and emergency department (ED) settings.

METHODS: We conducted a systematic review and meta-analysis. PubMed, SCOPUS, Cochrane Library, Web of Science, and EMBASE were searched from inception to February 2025, with an update in July 2025. Eligible studies enrolled trauma patients with reported ETCO₂ and stratified outcomes by low versus normal/high ETCO₂ (as defined by the original authors). The primary outcome was all-cause mortality; the secondary outcome was receipt of any blood transfusion. Random-effects models generated pooled odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity, sensitivity, publication bias, and moderator/meta-regression analyses were performed.

RESULTS: Eight observational studies (n= 2,407) met the inclusion criteria: three prospective Emergency Department-based and 5 retrospective prehospital cohorts. All studies were based in the United States. Overall, 732 (30%) patients had low ETCO₂. Low ETCO₂ was associated with significantly higher mortality (21.8% vs. 12.0%); pooled OR 9.59 (95% CI: 3.35-27.49; P <0.001). Findings were robust to one-study-removed sensitivity analyses (OR range 5.88-15.23). Prospective ED studies demonstrated lower heterogeneity ( I ²≈28%) than retrospective studies ( I ²≈83%). Thresholds defining "low" ETCO₂ varied (≤30-≤33 mm Hg). Meta-regression showed higher initial systolic blood pressure correlated with lower mortality odds (corr. coeff. -0.101; 95% CI: -0.17 to -0.029; P =0.0054). Four studies reporting transfusion showed higher odds with low ETCO₂ (7.4% vs. 1.3%); pooled OR: 3.32 (95% CI: 2.12-6.15; P <0.001).

CONCLUSIONS: Low ETCO 2 is strongly associated with increased mortality and transfusion in the trauma population. Given its low cost and noninvasive nature, prehospital and Emergency department ETCO 2 measurement and use for risk stratification should be considered. Standardized thresholds for low, normal, and high ETCO 2 and prospective studies are needed to optimize clinical implementation. ( J Trauma Acute Care Surg . 2026;101: 331-339. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).

LEVEL OF EVIDENCE: Systematic Review/Meta-analysis; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Rodriguez KA, Tran QK, Ali M, et al. End-tidal carbon dioxide as a predictor of mortality in trauma patients: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2026. PMID: 41879772. doi:10.1097/TA.0000000000004968

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。